MAY 08, 2018 09:46 PM PDT

No More Hair Loss? Osteoporosis Drug Treats Baldness

WRITTEN BY: Nouran Amin

 

 

According to The University of Manchester's Centre for Dermatology Research, a recent developed drug can lessen the stress experienced by both men and women who suffer from hair loss. Results from this study were published in PLOS Biology from the laboratory of Prof Ralf Paus.

The results indicate that the drug originally developed for treating osteoporosis produced a dramatic positive effect on human hair follicles donated by patients undergoing hair transplantation surgery.

At the present day, they are currently only 2 drugs that are available for treating male-pattern balding (androgenetic alopecia). This was a doctoral project investigated by Dr. Nathan Hawkshaw and colleagues which aimed to examine how drugs can be developed to promote human hair growth with the intention of finding novel, well-tolerated agents for the treatment of hair loss.

This molecular approach was the first identify the mechanisms of an old immunosuppressive drug, Cyclosporine A (CsA). Interestingly, Cyclosporine A has been commonly used since the 1980s as a crucial drug that suppresses transplant rejection and autoimmune diseases. Unfortunately, it holds severe-side effects such as the continuous growth of unwanted hair.

The investigative team worked on a full gene expression analysis of isolated human scalp hair follicles treated with CsA. This revealed that CsA reduces the expression of SFRP1, which is a protein that inhibits the development and growth of many tissues, including hair follicles. This identifies a completely novel mechanism of action of the old and widely used immunosuppressant.

Additionally, the team also examined why CsA induces hair growth which was found to be from a molecular pathway that antagonizes the SFRP1 protein.

Dr. Hawkshaw explains; "The fact this new agent, which had never even been considered in a hair loss context, promotes human hair growth is exciting because of its translational potential: it could one day make a real difference to people who suffer from hair loss. This makes our research clinically very relevant, as many hair research studies only use cell culture."

"Clearly though, a clinical trial is required next to tell us whether this drug or similar compounds are both effective and safe in hair loss patients."

 

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 09, 2018
Drug Discovery
OCT 09, 2018
Weight Loss Drug Reduces Incidence of Diabetes
A clinical trial weight loss drug, by the name of Lorcaserin—manufactured by Eisai Inc., was found to reduce the risk of diabetes by 19 percent in pa...
NOV 30, 2018
Immunology
NOV 30, 2018
Aspirin May Impove MS Symptoms
The medical benefits of aspirin have been known since ancient times. Hippocrates, c. 400 BC, prescribed the salicylate-rich bark and leaves of the willow t...
DEC 05, 2018
Videos
DEC 05, 2018
Male Contraceptive Gel is in Clinical Trials
Researchers have started a clinical trial involving 420 participants to test the efficacy of a male contraceptive gel....
DEC 09, 2018
Cannabis Sciences
DEC 09, 2018
Targeting CB1 Endocannabinoid Receptor: Specificity is the Key
The human endocannabinoid system (ECS) is one of the body's largest network of neurotransmitters, receptors, and neuromodulators. This system plays a r...
JAN 07, 2019
Drug Discovery
JAN 07, 2019
First-in-Human Trial of Senolytic Drugs
According to a study published in the journal EBioMedicine, the very first results on the treatment of a deadly age-related disease in human patients using...
FEB 04, 2019
Microbiology
FEB 04, 2019
Potential New Antibiotic is Made by an Insect-linked Microbe
Like many other organisms, bacteria have to compete for resources and have developed a wide array of strategies to use, including antibiotics....
Loading Comments...